Research date · 19 August 2026

One supplement opportunity worth testing now.

A market, science, consumer-problem and competition analysis across 50 product concepts. The decision is intentionally narrow: solve a real problem before manufacturing another tub of vaguely optimistic powder.

Concepts screened50Across 10+ demand clusters

Top score8.62Evidence-weighted / 10

Primary trendGLP-1Companion nutrition

White spaceSavoryComplete protein for small appetite

If we launch only one

Reduced-appetite savory complete-protein broth

20 g of complete protein in a light savory cup for people who struggle with sweet, thick protein shakes during periods of reduced appetite. GLP-1 users are the initial acquisition wedge, not the entire brand identity.

20 g complete proteinsingle-serve sachetno added sugarlight savory tasteEU-first compliance

Why it wins

Protein need is well supported. GLP-1 adoption is expanding. Sweet and texture aversion is visible in consumer conversations. Generic GLP-1 shakes are already crowded, but savory high-quality protein is still fragmented across bariatric, bone-broth and cooking products.

Market signals

What changed by 2026

01 · GLP-1 is becoming a nutrition market

Nestlé, Myprotein, Applied Nutrition, Arla and others are building around smaller portions, protein, hydration and nutrient density.

02 · Protein demand is not theoretical

Reuters reports GLP-1 use is contributing to exceptional whey demand and high input prices. That validates demand but makes raw-material economics a real risk.

03 · Generic GLP-1 support is already crowded

Vitafoods 2026 industry feedback described GLP-1 support as overhyped. The opportunity is not another generic “GLP-1 stack.”

04 · Format is the opening

Consumer discussions repeatedly mention thick-shake fatigue, sweetness, nausea and use of clear protein, unflavoured protein or broth as workarounds.

05 · Savory protein is emerging

Bone broth and savory protein formats are appearing in functional beverages and protein soups, but are not yet the default GLP-1 proposition in Europe.

06 · Women 40+ remains the best alternative thesis

Creatine, muscle health and menopause are converging, but the category is filling quickly and pure creatine is easy to copy.

Weighted opportunity model

Top 10

1. Reduced-appetite savory protein broth8.62

2. Low-sweet clear protein + creatine8.40

3. GLP-1 55+ protein + creatine8.30

4. Perimenopause 5g creatine stick8.18

5. GLP-1 women 40+ muscle formula8.15

6. Active aging creatine + HMB8.10

7. Compact 100ml protein shot8.07

8. Women 40+ protein + creatine8.07

9. 60+ creatine 3g daily8.07

10. GLP-1 gentle fiber stick8.05

#	Concept	Score	Problem	Demand	Gap	Science	Biggest risk
1	Reduced-appetite savory protein broth GLP-1 / weight management	8.62	9	9	8.5	9	Sensory execution and whey cost
2	Low-sweet clear protein + creatine GLP-1 / weight management	8.40	9	9	7.5	9	Clear protein is already crowded
3	GLP-1 55+ protein + creatine GLP-1 / active aging	8.30	9	8.5	7.5	9	Narrower segment and claim discipline
4	Perimenopause 5g creatine stick Women 40+	8.18	8	8.5	5.5	8.5	Easy to copy; category is filling fast
5	GLP-1 women 40+ muscle formula GLP-1 / women 40+	8.15	9	8	7.5	8.5	Medical-adjacent positioning risk
6	Active aging creatine + HMB Healthy aging	8.10	8.5	7.5	7.5	8	HMB awareness is low
7	Compact 100ml protein shot GLP-1 / medical nutrition	8.07	9	9	6.5	9	Liquid manufacturing complexity
8	Women 40+ protein + creatine Women 40+	8.07	8.5	8.5	6.5	9	Crowding and generic positioning
9	60+ creatine 3g daily Healthy aging	8.07	8	7.5	6	8.5	Generic powder has low moat
10	GLP-1 gentle fiber stick GLP-1 / gut health	8.05	8	8.5	6	7	Can worsen GI symptoms if poorly dosed

Weights: problem 15%, demand 15%, growth 10%, competition gap 15%, science 10%, repeat 10%, margin 10%, clarity 5%, regulatory simplicity 5%, speed 5%. Scores are analyst judgements grounded in the cited evidence set, not audited market measurements.

Deep dive

Top 3

1 · Savory complete-protein broth · 8.62

Problem: reduced appetite plus protein targets, with a subgroup that finds sweet or thick shakes hard to tolerate. Gap: savory whey soups exist, GLP-1 protein products exist, but the overlap is still weakly owned. Commercial thesis: the message is immediately understandable and naturally repeatable. Risk: sensory quality and elevated whey costs.

2 · Low-sweet clear protein + creatine · 8.40

Excellent science and clear GLP-1 relevance. It loses to the winner because clear protein is already common and creatine is rapidly commoditizing. A strong line extension after product-market fit.

3 · GLP-1 55+ protein + creatine · 8.30

Strong intersection of active aging, muscle preservation and GLP-1. EU creatine claims are more useful for adults over 55 when resistance-training conditions are met. The market is smaller but strategically attractive.

V1 product specification

PRO20 Savory Protein Broth

Formula direction

Protein: 20 g complete high-quality protein per serving. Start with instantized whey protein isolate or a complete whey-rich system.

Flavor: light chicken & herb as the first prototype. Tomato-herb and mild miso/umami as sensory challengers.

Serving: approximately 24-28 g powder in 200-250 ml warm water.

V1 exclusions: no high fiber, no huge micronutrient stack, no botanical kitchen sink. Every extra ingredient is another way for taste, claims or tolerance to become annoying.

Creatine: reserve for V2 unless manufacturer testing shows clean sensory performance and claims strategy is approved.

Commercial targets

Starter: 14 sachets · €39

Monthly: 28 sachets · €69

Subscription: €62-65

Target COGS, 14 pack: €10-16 at low scale, strategy estimate only.

MOQ discussion: around 100 kg test batch or 500-2,000 retail units, supplier dependent.

Gross-margin gate: credible path to 60%+ at ~2,000 units.

EU claims rule: build packaging around authorized protein claims such as contribution to maintenance/growth of muscle mass when conditions are met. Do not claim treatment of nausea, medication side effects or GLP-1-induced muscle loss. Final label and campaign copy require regulatory review in the launch countries.

White-space test

Competition is real. The exact proposition is still fragmented.

Product	Segment	Formula	Format	Strategic read
Myprotein Bone Broth Protein	Savory broth protein	12 g protein, mostly collagen	Savory warm powder	Not GLP-1 specific; lower complete-protein quality for muscle target
UNJURY Chicken Soup	Savory whey protein soup	Whey protein isolate	Bariatric / medical-adjacent	Strong proof of format; US-oriented
HSN Chicken Protein Broth	Savory protein broth	Chicken protein + collagen	Cooking / broth	EU product; not positioned around reduced appetite or GLP-1
Future Nutrition GLP-1 Protein+	Compact GLP-1 shot	20 g protein + 5 g fiber + micronutrients	100 ml shot	Direct GLP-1 competitor but liquid and non-savory
Myprotein GLP-1 Nutrition Support	GLP-1 range	Protein + multiple supplements	Broad support range	Large brand, but mostly conventional formats
Applied Nutrition GLP-1 Friendly	GLP-1 range	Protein, creatine, hydration, digestion	Broad support range	Crowded general support positioning
The Protein Works GLP-1 Shakes	GLP-1 meal shakes	High protein complete meal	Sweet shake	Direct alternative but texture/sweetness remain the gap
Arla BLG-100 concept	Compact protein technology	21 g / 100 ml	Ingredient / B2B concept	Proves technical feasibility, not a consumer brand
Ancient Nutrition Bone Broth Protein	Bone broth powder	~20 g protein	Broth / shake	Strong bone-broth brand, not GLP-1 specific
Meal Boosters Savory Protein	Savory meal enhancer	15-20 g protein	Food enhancer	Shows no-sweet protein demand, not reduced-appetite positioning

Red Team: This is not an ingredient moat. Myprotein or another large brand could copy the format. The defensibility must come from brand ownership of “protein for small-appetite days,” superior taste, clinical/advisory credibility, community distribution and speed.

30-day validation

Do not manufacture first.

Week 1 · Problem

15-20 interviews. Test three propositions before explaining the thesis. Measure current routine, pain, flavor, price and switching intent.

Week 2 · Demand

Landing page, search-intent traffic, creators and community outreach. CTA to waitlist and refundable reservation where legally appropriate.

Week 3 · Sensory

Three bench prototypes. 20-30 target consumers. Blind scoring for taste, aroma, texture, satiety and repeat intent.

Week 4 · Economics

Three supplier quotes. Model 500, 2,000 and 10,000 units. Decide go, reformulate or kill.

Go thresholds

12%+ waitlist conversion on high-intent traffic · 40%+ say it would replace an existing protein solution · 25%+ accept €39/14-serving target in qualified interviews · 7/10+ sensory average · 3%+ refundable reservation conversion · credible 60%+ gross margin at 2,000 units.

Kill thresholds

Kill or radically reposition if two occur: waitlist below 6%, paid intent below 1%, sensory below 6/10, or no path to 50% gross margin at 2,000 units.

What not to launch first

Three tempting traps

Generic magnesium sleep

Demand is enormous. White space is miserable. Brand-building costs become the product.

Generic menopause creatine

Strong trend, good science, beautiful margins. Also trivial to copy and already filling rapidly.

Kitchen-sink GLP-1 stack

The category is already crowded and every extra ingredient raises sensory, tolerance and regulatory complexity.

Longevity novelty ingredients

Interesting science stories, weaker claims, higher cost and more EU regulatory friction than the first launch needs.

Evidence base

Sources

AJoint advisory: Nutritional priorities to support GLP-1 therapy for obesityPubMed / AJCN · 2025
Adequate protein, GI management, nutrient density and resistance training are core priorities for GLP-1 users.
ANestlé looks to develop new products to serve users of weight-loss drugsReuters · 2026-08-17
Large consumer companies are actively building GLP-1 companion nutrition around protein and rapid-weight-loss concerns.
AWeight-loss drugs fuel protein-rich whey cravingReuters · 2026-05-05
GLP-1 adoption is materially increasing protein demand and whey input prices.
ABig Food Is Fighting to Tempt Taste Buds in the Era of Weight-Loss DrugsWall Street Journal · 2026-08-19
GLP-1 use is changing appetite, portion size, taste and product formulation priorities.
AFood companies target GLP-1 users with GLP-1 Friendly labelsAssociated Press · 2026
Smaller nutrient-dense portions, protein, fiber and hydration are recurring needs; GLP-1 Friendly is not an official US regulatory designation.
AEU Register nutrition and health claimsEuropean Commission · current
Authorized EU health claims and conditions of use.
AEU Novel Food consultation processEuropean Commission · current
Creatine monohydrate and micronised creatine monohydrate are listed as not novel; other creatine forms may differ.
BArla Foods Ingredients targets GLP-1 companion nutritionArla Foods Ingredients · 2026-04-15
Technical feasibility of 21 g protein in a 100 ml water-based shot and small appetite formats.
BVitafoods 2026 trends that matteredSirio Europe · 2026
Women’s health, longevity and format innovation were strong; generic GLP-1 support was viewed as overhyped.
BVitafoods Europe 2026 spotlight on healthy aging and women’s healthNutrition Insight · 2026-05-13
Women’s health and menopause remain active product development areas.
ACreatine monohydrate for lean mass, strength and bone outcomes in postmenopausal womenPubMed · 2026
Recent evidence supports small meaningful lean mass and strength gains with creatine plus resistance training in postmenopausal women.
ACreatine in women’s health: bridging the gapPubMed · 2025
Reviews creatine across women’s health and identifies promising applications.
ACreatine + HMB randomized crossover trial in older adultsPubMed · 2026
Creatine plus HMB improved multiple functional strength outcomes in physically active adults 60+.
AWhey but not collagen peptides stimulate muscle protein synthesisPubMed · 2020
Supports preference for complete high-quality protein over collagen-only positioning for muscle-focused product.
BMyprotein Bone Broth ProteinMyprotein · current
Savory broth format exists but current example provides 12 g protein, largely collagen.
BUNJURY high protein soupsUNJURY · current
Shows savory whey protein soup is technically and commercially feasible in bariatric nutrition.
BHSN Chicken Protein Broth PowderHSN · current
Savory chicken-protein broth format exists in Europe, but is not GLP-1-specific.
BFuture Nutrition GLP-1 Protein+ 100 ml shotFuture Nutrition · current
Direct evidence that GLP-1 users are being targeted with compact 20 g protein formats.
BMyprotein GLP-1 Nutrition SupportMyprotein · current
Major sports-nutrition brand now has a dedicated GLP-1 support range.
BApplied Nutrition GLP-1 Friendly CollectionApplied Nutrition · current
Shows category expansion across hydration, digestion, creatine and protein.
BProtein Works GLP-1 Friendly ShakesThe Protein Works · current
Nutritionally complete GLP-1 shakes show the mainstream shake segment is already populated.
BBone broth breaks out of the soup bowlFoodNavigator · 2026-07-02
Savory protein and bone-broth beverages are moving into broader functional beverage culture.
CFrom Matcha to Martinis, Bone Broth Is Suddenly EverywhereGood Housekeeping · 2026-08-18
Consumer trend signal for savory protein-rich beverages.
CReddit: Mounjaro protein shake discussionReddit · 2026
Consumer reports clear protein can still be too sweet and gets diluted.
CReddit: GLP-1 protein struggle / clear proteinReddit · 2026
Consumer reports thick shakes become tiring and clear protein is easier.
CReddit: Zepbound cannot tolerate sweet thingsReddit · 2025
Direct voice-of-customer evidence for sweet aversion and use of broth/unflavoured protein.
CReddit: protein shakes when nausea is highReddit · 2024
Texture can trigger nausea and users seek alternatives.
CPrivate label whey protein guide 2026Envir · 2026-03-27
Directional manufacturing signal: test-batch MOQs can begin around 100 kg; supplier quote required.
CPrivate label protein manufacturersRain Nutrience · current
European/UK contract manufacturers offer protein powder and sachet formats.

Method limitation: this run did not individually verify 1,000 complete Amazon/iHerb reviews because the available search interface does not expose a reproducible full review corpus. Consumer evidence here is directional, based on indexed public discussions and product pages. Before capital commitment, acquire/export a 1,000+ review corpus and repeat the text-mining stage.